SMTN
Basic information
Region (hg38): 22:31064105-31104757
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SMTN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 65 | 69 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 12 | |||||
Total | 0 | 0 | 74 | 6 | 4 |
Variants in SMTN
This is a list of pathogenic ClinVar variants found in the SMTN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-31082927-G-A | not specified | Uncertain significance (Jul 25, 2023) | ||
22-31082955-C-T | not specified | Likely benign (May 08, 2023) | ||
22-31082956-G-A | Benign (Sep 11, 2018) | |||
22-31082988-C-G | not specified | Uncertain significance (Jun 23, 2021) | ||
22-31083183-C-A | not specified | Uncertain significance (May 24, 2024) | ||
22-31083235-C-A | not specified | Uncertain significance (Sep 26, 2024) | ||
22-31083236-C-T | not specified | Uncertain significance (Aug 11, 2022) | ||
22-31083255-C-A | not specified | Uncertain significance (Aug 16, 2022) | ||
22-31083256-G-A | not specified | Likely benign (Nov 25, 2024) | ||
22-31083263-C-T | not specified | Uncertain significance (Oct 01, 2024) | ||
22-31083268-G-A | not specified | Uncertain significance (May 05, 2023) | ||
22-31083286-G-C | not specified | Uncertain significance (May 01, 2022) | ||
22-31083296-C-T | not specified | Uncertain significance (May 16, 2023) | ||
22-31087980-G-A | not specified | Uncertain significance (Jun 26, 2023) | ||
22-31087998-C-T | not specified | Uncertain significance (Jul 31, 2024) | ||
22-31087999-G-T | not specified | Uncertain significance (Dec 28, 2022) | ||
22-31088016-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
22-31088017-G-A | not specified | Uncertain significance (Oct 11, 2024) | ||
22-31088049-G-C | not specified | Uncertain significance (Aug 12, 2021) | ||
22-31088086-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
22-31088108-G-C | not specified | Uncertain significance (Mar 24, 2023) | ||
22-31088523-C-T | not specified | Uncertain significance (Mar 14, 2023) | ||
22-31088583-G-A | not specified | Uncertain significance (Sep 22, 2023) | ||
22-31088726-C-A | not specified | Uncertain significance (Apr 12, 2022) | ||
22-31088751-G-A | not specified | Uncertain significance (Oct 03, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SMTN | protein_coding | protein_coding | ENST00000358743 | 20 | 40653 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.60e-7 | 1.00 | 125703 | 0 | 45 | 125748 | 0.000179 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.791 | 558 | 613 | 0.910 | 0.0000416 | 5938 |
Missense in Polyphen | 181 | 221.27 | 0.81801 | 2046 | ||
Synonymous | 1.63 | 212 | 244 | 0.867 | 0.0000153 | 2033 |
Loss of Function | 3.73 | 20 | 47.9 | 0.418 | 0.00000300 | 481 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000276 | 0.000272 |
Ashkenazi Jewish | 0.000301 | 0.000298 |
East Asian | 0.000232 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000228 | 0.000220 |
Middle Eastern | 0.000232 | 0.000217 |
South Asian | 0.000231 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Structural protein of the cytoskeleton.;
Recessive Scores
- pRec
- 0.135
Intolerance Scores
- loftool
- 0.675
- rvis_EVS
- 0.43
- rvis_percentile_EVS
- 77.33
Haploinsufficiency Scores
- pHI
- 0.190
- hipred
- N
- hipred_score
- 0.497
- ghis
- 0.484
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.259
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Smtn
- Phenotype
- immune system phenotype; digestive/alimentary phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); muscle phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
Gene ontology
- Biological process
- smooth muscle contraction;muscle organ development;actin cytoskeleton organization
- Cellular component
- cytoplasm;microtubule organizing center;cytoskeleton;actin cytoskeleton;filamentous actin
- Molecular function
- actin binding;structural constituent of muscle